Immix Historical Cash Flow
| IMMX Stock | USD 1.94 0.03 1.52% |
Analysis of Immix Biopharma cash flow over time is an excellent tool to project Immix Biopharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 2 M or Begin Period Cash Flow of 16.2 M as it is a great indicator of Immix Biopharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Immix Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immix Biopharma is a good buy for the upcoming year.
Immix |
About Immix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Immix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Immix's non-liquid assets can be easily converted into cash.
Immix Biopharma Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Immix Biopharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Change To Inventory is fairly stable compared to the past year. Change In Working Capital is likely to rise to about 2 M in 2025, despite the fact that Investments are likely to grow to (33.3 K).
Immix Biopharma cash flow statement Correlations
Click cells to compare fundamentals
Immix Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immix Biopharma cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (342.9K) | 17.3M | (4.2M) | 4.1M | 4.7M | 3.8M | |
| Free Cash Flow | (404.7K) | (1.6M) | (7.4M) | (11.4M) | (10.3M) | (9.8M) | |
| Change In Working Capital | 165.8K | (391.0K) | 195.2K | 1.7M | 1.9M | 2.0M | |
| Begin Period Cash Flow | 734.0K | 391.1K | 17.6M | 13.4M | 15.5M | 16.2M | |
| Other Cashflows From Financing Activities | 468.3K | (802.0) | (56.7K) | (229.4K) | (206.4K) | (196.1K) | |
| Depreciation | 2.3K | 2.5K | 2.1K | 5.5K | 6.3K | 6.6K | |
| Other Non Cash Items | 575K | 118.2K | 100K | 2.3M | 2.6M | 2.7M | |
| Total Cash From Operating Activities | (404.7K) | (1.6M) | (7.4M) | (11.4M) | (10.2M) | (9.7M) | |
| Change To Account Receivables | 58.5K | 97.7K | (236.4K) | (893.4K) | (804.1K) | (763.9K) | |
| Net Income | (1.1M) | (24.4M) | (8.2M) | (15.6M) | (14.0M) | (14.7M) | |
| End Period Cash Flow | 391.1K | 17.6M | 13.4M | 17.5M | 20.1M | 10.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.